This comprehensive report provides a detailed analysis of the global functional genomics market, projecting its growth trajectory through 2032. The study examines key segments including kits, assays, and instruments, while categorizing applications such as transcriptomics, epigenomics, proteomics, and metabolomics. By evaluating regional dynamics across the Americas, APAC, Europe, and MEA, the report identifies emerging opportunities and competitive strategies. It also profiles leading industry players, offering insights into their market positions, product portfolios, and recent technological developments.

Executive Overview

Market Projections

• Global Market: The global Functional Genomics market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate.
• United States Market: The market for Functional Genomics in the United States is estimated to increase steadily from 2025 through 2032.
• China Market: The market for Functional Genomics in China is estimated to undergo consistent expansion between 2025 and 2032.
• Europe Market: The market for Functional Genomics in Europe is expected to grow throughout the forecast period from 2025 to 2032.

Report Scope and Methodology

LPI (LP Information)' newest research report, the “Functional Genomics Industry Forecast,” reviews total world Functional Genomics sales in 2025 by looking at past sales. It provides a comprehensive analysis by region and market sector of projected Functional Genomics sales for 2026 through 2032. With Functional Genomics sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Functional Genomics industry.

This Insight Report provides a comprehensive analysis of the global Functional Genomics landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies with a focus on Functional Genomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Functional Genomics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Functional Genomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Functional Genomics. The report presents a comprehensive overview, market shares, and growth opportunities of the Functional Genomics market by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Kits & Assays
• Instruments
• Assays

By Application

• Transcriptomics
• Epigenomics
• Proteomics
• Metabolomics

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Concentration

Global key Functional Genomics players include Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc. (Integrated DNA Technologies, Inc.), and Exact Sciences Corporation. In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

Key Vendors

The following companies have been profiled based on inputs gathered from primary experts and analysis of the company's coverage, product portfolio, and market penetration:

• Agilent Technologies, Inc.
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc. (Integrated DNA Technologies, Inc.)
• Exact Sciences Corporation
• Hoffmann-La Roche Ltd
• Illumina, Inc.
• Merck KGaA
• MRM Proteomics
• Pacific Biosciences of California, Inc.
• Promega Corporation
• QIAGEN
• Thermo Fisher Scientific Inc.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Functional Genomics Market Size (2021-2032)

    • 2.1.2 Functional Genomics Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Functional Genomics by Country/Region (2021, 2025 & 2032)

  • 2.2 Functional Genomics Segment by Type

    • 2.2.1 Kits & Assays

    • 2.2.2 Instruments

    • 2.2.3 Assays

    • 2.2.4 Functional Genomics Market Size by Type

      • 2.2.4.1 Functional Genomics Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Functional Genomics Market Size Market Share by Type (2021-2026)

  • 2.3 Functional Genomics Segment by Application

    • 2.3.1 Transcriptomics

    • 2.3.2 Epigenomics

    • 2.3.3 Proteomics

    • 2.3.4 Metabolomics

    • 2.3.5 Functional Genomics Market Size by Application

      • 2.3.5.1 Functional Genomics Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Functional Genomics Market Size Market Share by Application (2021-2026)

• 3 Functional Genomics Market Size by Player

  • 3.1 Functional Genomics Market Size Market Share by Player

    • 3.1.1 Global Functional Genomics Revenue by Player (2021-2026)

    • 3.1.2 Global Functional Genomics Revenue Market Share by Player (2021-2026)

  • 3.2 Global Functional Genomics Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Functional Genomics by Region

  • 4.1 Functional Genomics Market Size by Region (2021-2026)

  • 4.2 Global Functional Genomics Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Functional Genomics Market Size Growth (2021-2026)

  • 4.4 APAC Functional Genomics Market Size Growth (2021-2026)

  • 4.5 Europe Functional Genomics Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Functional Genomics Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Functional Genomics Market Size by Country (2021-2026)

  • 5.2 Americas Functional Genomics Market Size by Type (2021-2026)

  • 5.3 Americas Functional Genomics Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Functional Genomics Market Size by Region (2021-2026)

  • 6.2 APAC Functional Genomics Market Size by Type (2021-2026)

  • 6.3 APAC Functional Genomics Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Functional Genomics Market Size by Country (2021-2026)

  • 7.2 Europe Functional Genomics Market Size by Type (2021-2026)

  • 7.3 Europe Functional Genomics Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Functional Genomics by Region (2021-2026)

  • 8.2 Middle East & Africa Functional Genomics Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Functional Genomics Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Functional Genomics Market Forecast

  • 10.1 Global Functional Genomics Forecast by Region (2027-2032)

    • 10.1.1 Global Functional Genomics Forecast by Region (2027-2032)

    • 10.1.2 Americas Functional Genomics Forecast

    • 10.1.3 APAC Functional Genomics Forecast

    • 10.1.4 Europe Functional Genomics Forecast

    • 10.1.5 Middle East & Africa Functional Genomics Forecast

  • 10.2 Americas Functional Genomics Forecast by Country (2027-2032)

    • 10.2.1 United States Market Functional Genomics Forecast

    • 10.2.2 Canada Market Functional Genomics Forecast

    • 10.2.3 Mexico Market Functional Genomics Forecast

    • 10.2.4 Brazil Market Functional Genomics Forecast

  • 10.3 APAC Functional Genomics Forecast by Region (2027-2032)

    • 10.3.1 China Functional Genomics Market Forecast

    • 10.3.2 Japan Market Functional Genomics Forecast

    • 10.3.3 Korea Market Functional Genomics Forecast

    • 10.3.4 Southeast Asia Market Functional Genomics Forecast

    • 10.3.5 India Market Functional Genomics Forecast

    • 10.3.6 Australia Market Functional Genomics Forecast

  • 10.4 Europe Functional Genomics Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Functional Genomics Forecast

    • 10.4.2 France Market Functional Genomics Forecast

    • 10.4.3 UK Market Functional Genomics Forecast

    • 10.4.4 Italy Market Functional Genomics Forecast

    • 10.4.5 Russia Market Functional Genomics Forecast

  • 10.5 Middle East & Africa Functional Genomics Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Functional Genomics Forecast

    • 10.5.2 South Africa Market Functional Genomics Forecast

    • 10.5.3 Israel Market Functional Genomics Forecast

    • 10.5.4 Turkey Market Functional Genomics Forecast

  • 10.6 Global Functional Genomics Forecast by Type (2027-2032)

  • 10.7 Global Functional Genomics Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Functional Genomics Forecast

• 11 Key Players Analysis

  • 11.1 Agilent Technologies, Inc.

    • 11.1.1 Agilent Technologies, Inc. Company Information

    • 11.1.2 Agilent Technologies, Inc. Functional Genomics Product Offered

    • 11.1.3 Agilent Technologies, Inc. Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Agilent Technologies, Inc. Main Business Overview

    • 11.1.5 Agilent Technologies, Inc. Latest Developments

  • 11.2 Becton, Dickinson and Company (BD)

    • 11.2.1 Becton, Dickinson and Company (BD) Company Information

    • 11.2.2 Becton, Dickinson and Company (BD) Functional Genomics Product Offered

    • 11.2.3 Becton, Dickinson and Company (BD) Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Becton, Dickinson and Company (BD) Main Business Overview

    • 11.2.5 Becton, Dickinson and Company (BD) Latest Developments

  • 11.3 Bio-Rad Laboratories, Inc.

    • 11.3.1 Bio-Rad Laboratories, Inc. Company Information

    • 11.3.2 Bio-Rad Laboratories, Inc. Functional Genomics Product Offered

    • 11.3.3 Bio-Rad Laboratories, Inc. Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Bio-Rad Laboratories, Inc. Main Business Overview

    • 11.3.5 Bio-Rad Laboratories, Inc. Latest Developments

  • 11.4 (Integrated DNA Technologies, Inc.)

    • 11.4.1 (Integrated DNA Technologies, Inc.) Company Information

    • 11.4.2 (Integrated DNA Technologies, Inc.) Functional Genomics Product Offered

    • 11.4.3 (Integrated DNA Technologies, Inc.) Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 (Integrated DNA Technologies, Inc.) Main Business Overview

    • 11.4.5 (Integrated DNA Technologies, Inc.) Latest Developments

  • 11.5 Exact Sciences Corporation

    • 11.5.1 Exact Sciences Corporation Company Information

    • 11.5.2 Exact Sciences Corporation Functional Genomics Product Offered

    • 11.5.3 Exact Sciences Corporation Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Exact Sciences Corporation Main Business Overview

    • 11.5.5 Exact Sciences Corporation Latest Developments

  • 11.6 Hoffmann-La Roche Ltd

    • 11.6.1 Hoffmann-La Roche Ltd Company Information

    • 11.6.2 Hoffmann-La Roche Ltd Functional Genomics Product Offered

    • 11.6.3 Hoffmann-La Roche Ltd Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Hoffmann-La Roche Ltd Main Business Overview

    • 11.6.5 Hoffmann-La Roche Ltd Latest Developments

  • 11.7 Illumina, Inc.

    • 11.7.1 Illumina, Inc. Company Information

    • 11.7.2 Illumina, Inc. Functional Genomics Product Offered

    • 11.7.3 Illumina, Inc. Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Illumina, Inc. Main Business Overview

    • 11.7.5 Illumina, Inc. Latest Developments

  • 11.8 Merck KGaA

    • 11.8.1 Merck KGaA Company Information

    • 11.8.2 Merck KGaA Functional Genomics Product Offered

    • 11.8.3 Merck KGaA Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Merck KGaA Main Business Overview

    • 11.8.5 Merck KGaA Latest Developments

  • 11.9 MRM Proteomics

    • 11.9.1 MRM Proteomics Company Information

    • 11.9.2 MRM Proteomics Functional Genomics Product Offered

    • 11.9.3 MRM Proteomics Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 MRM Proteomics Main Business Overview

    • 11.9.5 MRM Proteomics Latest Developments

  • 11.10 Pacific Biosciences of California, Inc.

    • 11.10.1 Pacific Biosciences of California, Inc. Company Information

    • 11.10.2 Pacific Biosciences of California, Inc. Functional Genomics Product Offered

    • 11.10.3 Pacific Biosciences of California, Inc. Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Pacific Biosciences of California, Inc. Main Business Overview

    • 11.10.5 Pacific Biosciences of California, Inc. Latest Developments

  • 11.11 Promega Corporation

    • 11.11.1 Promega Corporation Company Information

    • 11.11.2 Promega Corporation Functional Genomics Product Offered

    • 11.11.3 Promega Corporation Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Promega Corporation Main Business Overview

    • 11.11.5 Promega Corporation Latest Developments

  • 11.12 QIAGEN

    • 11.12.1 QIAGEN Company Information

    • 11.12.2 QIAGEN Functional Genomics Product Offered

    • 11.12.3 QIAGEN Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 QIAGEN Main Business Overview

    • 11.12.5 QIAGEN Latest Developments

  • 11.13 Thermo Fisher Scientific Inc.

    • 11.13.1 Thermo Fisher Scientific Inc. Company Information

    • 11.13.2 Thermo Fisher Scientific Inc. Functional Genomics Product Offered

    • 11.13.3 Thermo Fisher Scientific Inc. Functional Genomics Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Thermo Fisher Scientific Inc. Main Business Overview

    • 11.13.5 Thermo Fisher Scientific Inc. Latest Developments

• 12 Research Findings and Conclusion